LitCovid-sample-Enju  

PMC:7253482 / 910-1255 JSONTXT 14 Projects

Annnotations TAB TSV DIC JSON TextAE

Id Subject Object Predicate Lexical cue
T140 3-7 NN denotes role
T141 8-10 IN denotes in
T142 11-20 VBG denotes shielding
T143 21-32 JJ denotes immunogenic
T144 33-41 NNS denotes epitopes
T145 43-50 RB denotes Overall
T146 50-51 -COMMA- denotes ,
T147 52-55 PRP-DOLLAR- denotes our
T148 56-60 NNS denotes data
T149 61-67 VBP denotes reveal
T150 68-71 WRB denotes how
T151 72-84 NN denotes organisation
T152 85-87 IN denotes of
T153 88-101 NN denotes glycosylation
T154 102-108 IN denotes across
T155 109-114 NN denotes class
T156 115-116 CD denotes I
T157 117-122 JJ denotes viral
T158 123-129 NN denotes fusion
T159 130-138 NNS denotes proteins
T160 139-148 VBP denotes influence
T161 149-152 RB denotes not
T162 153-157 RB denotes only
T163 158-168 JJ denotes individual
T164 169-175 NN denotes glycan
T165 176-188 NNS denotes compositions
T166 189-192 CC denotes but
T167 193-197 RB denotes also
T168 198-201 DT denotes the
T169 202-215 JJ denotes immunological
T170 216-224 NN denotes pressure
T171 225-231 IN denotes across
T172 232-235 DT denotes the
T173 236-243 NN denotes protein
T174 244-251 NN denotes surface
T175 254-267 NN denotes Glycosylation
T176 268-273 VBZ denotes plays
T177 274-275 DT denotes a
T178 276-279 JJ denotes key
T179 280-284 NN denotes role
T180 285-287 IN denotes in
T181 288-297 NN denotes shielding
T182 298-300 IN denotes of
T183 301-312 JJ denotes immunogenic
T184 313-321 NNS denotes epitopes
T185 322-324 IN denotes on
T186 325-330 JJ denotes viral
T187 331-336 NN denotes spike
T188 337-338 -LRB- denotes (
T189 338-339 NN denotes S
T190 339-340 -RRB- denotes )
R138 T142 T141 arg2Of shielding,in
R139 T144 T142 arg2Of epitopes,shielding
R140 T144 T143 arg1Of epitopes,immunogenic
R141 T149 T145 arg1Of reveal,Overall
R142 T149 T146 arg1Of reveal,","
R143 T148 T147 arg1Of data,our
R144 T148 T149 arg1Of data,reveal
R145 T166 T149 arg2Of but,reveal
R146 T160 T150 arg1Of influence,how
R147 T151 T152 arg1Of organisation,of
R148 T153 T152 arg2Of glycosylation,of
R149 T151 T154 arg1Of organisation,across
R150 T159 T154 arg2Of proteins,across
R151 T159 T155 arg1Of proteins,class
R152 T159 T156 arg1Of proteins,I
R153 T159 T157 arg1Of proteins,viral
R154 T159 T158 arg1Of proteins,fusion
R155 T151 T160 arg1Of organisation,influence
R156 T165 T160 arg2Of compositions,influence
R157 T162 T161 arg1Of only,not
R158 T165 T162 arg1Of compositions,only
R159 T165 T163 arg1Of compositions,individual
R160 T165 T164 arg1Of compositions,glycan
R161 T150 T166 arg1Of how,but
R162 T170 T166 arg2Of pressure,but
R163 T166 T167 arg1Of but,also
R164 T170 T168 arg1Of pressure,the
R165 T170 T169 arg1Of pressure,immunological
R166 T170 T171 arg1Of pressure,across
R167 T174 T171 arg2Of surface,across
R168 T174 T172 arg1Of surface,the
R169 T174 T173 arg1Of surface,protein
R170 T175 T176 arg1Of Glycosylation,plays
R171 T179 T176 arg2Of role,plays
R172 T179 T177 arg1Of role,a
R173 T179 T178 arg1Of role,key
R174 T176 T180 arg1Of plays,in
R175 T181 T180 arg2Of shielding,in
R176 T181 T182 arg1Of shielding,of
R177 T184 T182 arg2Of epitopes,of
R178 T184 T183 arg1Of epitopes,immunogenic
R179 T181 T185 arg1Of shielding,on
R181 T187 T186 arg1Of spike,viral
R183 T187 T188 arg1Of spike,(
R184 T189 T188 arg2Of S,(
R185 T190 T188 arg3Of ),(